CoChat

Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Background: The importance of patient-reported outcome measurement in chronic kidney disease (CKD) populations has been established. However, there remains a lack of research that has synthesised data around CKD-specific symptom and health-related quality of life (HRQOL) burden globally, to inform focused measurement of the most relevant patient-important information in a way that minimises patient burden. The aim of this review was to synthesise symptom prevalence/severity and HRQOL data across the following CKD clinical groups globally: (1) stage 1–5 and not on renal replacement therapy (RRT), (2) receiving dialysis, or (3) in receipt of a kidney transplant. Methods and findings: MEDLINE, PsycINFO, and CINAHL were searched for English-language cross-sectional/longitudinal studies reporting prevalence and/or severity of symptoms and/or HRQOL in CKD, published between January 2000 and September 2021, including adult patients with CKD, and measuring symptom prevalence/severity and/or HRQOL using a patient-reported outcome measure (PROM). Random effects meta-analyses were used to pool data, stratified by CKD group: not on RRT, receiving dialysis, or in receipt of a kidney transplant. Methodological quality of included studies was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data, and an exploration of publication bias performed. The search identified 1,529 studies, of which 449, with 199,147 participants from 62 countries, were included in the analysis. Studies used 67 different symptom and HRQOL outcome measures, which provided data on 68 reported symptoms. Random effects meta-analyses highlighted the considerable symptom and HRQOL burden associated with CKD, with fatigue particularly prevalent, both in patients not on RRT (14 studies, 4,139 participants: 70%, 95% CI 60%–79%) and those receiving dialysis (21 studies, 2,943 participants: 70%, 95% CI 64%–76%). A number of symptoms were significantly ( p < 0.05 after adjustment for multiple testing) less prevalent and/or less severe within the post-transplantation population, which may suggest attribution to CKD (fatigue, depression, itching, poor mobility, poor sleep, and dry mouth). Quality of life was commonly lower in patients on dialysis (36-Item Short Form Health Survey [SF-36] Mental Component Summary [MCS] 45.7 [95% CI 45.5–45.8]; SF-36 Physical Component Summary [PCS] 35.5 [95% CI 35.3–35.6]; 91 studies, 32,105 participants for MCS and PCS) than in other CKD populations (patients not on RRT: SF-36 MCS 66.6 [95% CI 66.5–66.6], p = 0.002; PCS 66.3 [95% CI 66.2–66.4], p = 0.002; 39 studies, 24,600 participants; transplant: MCS 50.0 [95% CI 49.9–50.1], p = 0.002; PCS 48.0 [95% CI 47.9–48.1], p = 0.002; 39 studies, 9,664 participants). Limitations of the analysis are the relatively few studies contributing to symptom severity estimates and inconsistent use of PROMs (different measures and time points) across the included literature, which hindered interpretation. Conclusions: The main findings highlight the considerable symptom and HRQOL burden associated with CKD. The synthesis provides a detailed overview of the symptom/HRQOL profile across clinical groups, which may support healthcare professionals when discussing, measuring, and managing the potential treatment burden associated with CKD. Protocol registration: PROSPERO CRD42020164737.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003954

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 PRISMA diagram. CKD, chronic kidney disease; PROM, patient-reported outcome measure.
Fig 1 PRISMA diagram. CKD, chronic kidney disease; PROM, patient-reported outcome measure.CC BY · PubMed Central
Fig 2 Pooled prevalence of patient-reported symptoms across included studies for patients not on renal replacement therapy (RRT).
Fig 2 Pooled prevalence of patient-reported symptoms across included studies for patients not on renal replacement therapy (RRT).CC BY · PubMed Central
Fig 3 Pooled prevalence of patient-reported symptoms across included studies for patients on dialysis.
Fig 3 Pooled prevalence of patient-reported symptoms across included studies for patients on dialysis.CC BY · PubMed Central
Fig 4 Pooled prevalence of patient-reported symptoms across included studies for patients in receipt of a kidney transplant.
Fig 4 Pooled prevalence of patient-reported symptoms across included studies for patients in receipt of a kidney transplant.CC BY · PubMed Central
Fig 5 Pooled symptom severity across included studies for patients not on renal replacement therapy. Scores represent mean severity scores converted to a 0–100 scale, where a higher score indicates greater severity; vertical line at 50 for reference. RRT, renal replacement therapy.
Fig 5 Pooled symptom severity across included studies for patients not on renal replacement therapy. Scores represent mean severity scores converted to a 0–100 scale, where a higher score indicates greater severity; vertical line at 50 for reference. RRT, renal replacement therapy.CC BY · PubMed Central
Fig 6 Pooled symptom severity across included studies for patients on dialysis. Scores represent mean severity scores converted to a 0–100 scale, where a higher score indicates greater severity; vertical line at 50 for reference.
Fig 6 Pooled symptom severity across included studies for patients on dialysis. Scores represent mean severity scores converted to a 0–100 scale, where a higher score indicates greater severity; vertical line at 50 for reference.CC BY · PubMed Central
Fig 7 Pooled symptom severity across included studies for patients in receipt of a kidney transplant. Scores represent mean severity scores converted to a 0–100 scale, where a higher score indicates greater severity; vertical line at 50 for reference.
Fig 7 Pooled symptom severity across included studies for patients in receipt of a kidney transplant. Scores represent mean severity scores converted to a 0–100 scale, where a higher score indicates greater severity; vertical line at 50 for reference.CC BY · PubMed Central
Fig 8 Prevalence of fatigue in chronic kidney disease. See S4 Appendix for full references for included studies. ES, effect size; HD, haemodialysis; PD, peritoneal dialysis; RRT, renal replacement therapy.
Fig 8 Prevalence of fatigue in chronic kidney disease. See S4 Appendix for full references for included studies. ES, effect size; HD, haemodialysis; PD, peritoneal dialysis; RRT, renal replacement therapy.CC BY · PubMed Central
Fig 9 Symptom prevalence comparison across groups. CKD, chronic kidney disease; RRT, renal replacement therapy.
Fig 9 Symptom prevalence comparison across groups. CKD, chronic kidney disease; RRT, renal replacement therapy.CC BY · PubMed Central
Fig 10 Health-related quality of life in CKD. CKD, chronic kidney disease; EQ5D, EuroQoL–5 Dimension; KSS, Kidney Disease Quality of Life Summary Score; MCS, Mental Component Summary; No. pops, number of populations; PCS, Physical Component Summary; SF12, 12-Item Short Form Health Survey; SF36, 36-Item Short Form Health Survey.
Fig 10 Health-related quality of life in CKD. CKD, chronic kidney disease; EQ5D, EuroQoL–5 Dimension; KSS, Kidney Disease Quality of Life Summary Score; MCS, Mental Component Summary; No. pops, number of populations; PCS, Physical Component Summary; SF12, 12-Item Short Form Health Survey; SF36, 36-Item Short Form Health Survey.CC BY · PubMed Central
Fig 11 Quality of included studies. Yes = appraised as adequate; no = appraised as not adequate.
Fig 11 Quality of included studies. Yes = appraised as adequate; no = appraised as not adequate.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 414

Metadata

Authors
Fletcher, B. R., Damery, S., Aiyegbusi, O. L., Anderson, N., Calvert, M., Cockwell, P., Ferguson, J., Horton, M., Paap, M. C. S., Sidey-Gibbons, C., Slade, A., Turner, N., & Kyte, D.
Affiliations
  • University of Birmingham (GB)
  • National Institute for Health and Care Research (GB)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • NIHR Birmingham Biomedical Research Centre (GB)
  • University of Leeds (GB)
  • University of Groningen (NL)
  • The University of Texas MD Anderson Cancer Center (US)
  • Centre for Inflammation Research (GB)
Corresponding author
Kyte, Derek
Venue
PLOS Medicine
Published
2022-04-06
Volume
19
Issue
4
Pages
e1003954
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W4223633541
Cited by
414
References
35
Citations by year
2026: 121 · 2025: 136 · 2024: 93 · 2023: 52 · 2022: 11
FWCI
10.97
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Worcester Research and Publications (University of Worcester) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
Kidney Research UK (Stoneygate Research Award (KS_RP_20180914))
Topics
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
chronic kidney disease, symptom burden, health-related quality of life, patient-reported outcomes, fatigue, dialysis, kidney transplantation, renal replacement therapy, depression, pruritus, sleep disorders, xerostomia, mobility impairment, SF-36, SF-6D, SF-12, SF-1000
MeSH terms
Adult, Cross-Sectional Studies, Fatigue, Renal Dialysis, Humans, Quality of Life, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis. https://app.cochat.ai/papers/10.1371/journal.pmed.1003954
The paper
Fletcher, B. R., Damery, S., Aiyegbusi, O. L., Anderson, N., Calvert, M., Cockwell, P., Ferguson, J., Horton, M., Paap, M. C. S., Sidey-Gibbons, C., Slade, A., Turner, N., & Kyte, D. (2022). Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1003954

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.